Skip to content

Opening book details…

Can I read Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ on EtoBox?

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ by Shin‐ichiro Fujii; Satoru Yamasaki; Kenichi Hanada; Shogo Ueda; Masami Kawamura; Kanako Shimizu is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ about?

## Abstract NY‐ESO‐1 is a cancer/testis antigen expressed in various cancer types. However, the induction of NY‐ESO‐1‐specific CTLs through vaccines is somewhat difficult. Thus, we developed a new type of artificial adjuvant vector cell (aAVC‐NY‐ESO‐1) expressing a CD1d‐NKT cell ligand complex and a tumor‐associated antigen, NY‐ESO‐1. First, we determined the activation of invariant natural killer T (iNKT) and natural killer (NK) cell responses by aAVC‐NY‐ESO‐1. We then showed that the NY‐ESO‐1‐specific CTL response was successfully elicited through aAVC‐NY‐ESO‐1 therapy. After injection of aAVC‐NY‐ESO‐1, we found that dendritic cells (DCs) in situ expressed high levels of costimulatory molecules and produced interleukn‐12 (IL‐12), indicating that DCs undergo maturation in vivo. Furthermore, the NY‐ESO‐1 antigen from aAVC‐NY‐ESO‐1 was delivered to the DCs in vivo, and it was presented on MHC class I molecules. The cross‐presentation of the NY‐ESO‐1 antigen was absent in conventional DC‐deficient mice, suggesting a host DC‐mediated CTL response. Thus, this strategy helps generate sufficient CD8^+^ NY‐ESO‐1‐specific CTLs along with iNKT and NK cell activation, resulting in a strong a

Who reads Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Shin‐ichiro Fujii; Satoru Yamasaki; Kenichi Hanada; Shogo Ueda; Masami Kawamura; Kanako Shimizu
Publisher
Wiley
Published
2022
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Shin‐ichiro Fujii; Satoru Yamasaki; Kenichi Hanada; Shogo Ueda; Masami Kawamura; Kanako Shimizu

Browse all works by Shin‐ichiro Fujii; Satoru Yamasaki; Kenichi Hanada; Shogo Ueda; Masami Kawamura; Kanako Shimizu